Drug Information

Drug General Information
Drug ID
D0ZY2T
Former ID
DNC011811
Drug Name
PO3 2-Leu-Nal-O-3K
Drug Type
Small molecular drug
Indication Discovery agent Investigative [551263]
Structure
Download
2D MOL

3D MOL
Formula
C19H22K3N2O6P
Canonical SMILES
CC(C)CC(C(=O)NC(CC1=CC=CC2=CC=CC=C21)C(=O)[O-])NP(=O)([<br />O-])[O-].[K+].[K+].[K+]
InChI
1S/C19H25N2O6P.3K/c1-12(2)10-16(21-28(25,26)27)18(22)20-17(19(23)24)11-14-8-5-7-13-6-3-4-9-15(13)14;;;/h3-9,12,16-17H,10-11H2,1-2H3,(H,20,22)(H,23,24)(H3,21,25,26,27);;;/q;3*+1/p-3/t16-,17-;;;/m0.../s1
InChIKey
IKWJKNJQTURPIW-YKRIILNKSA-K
PubChem Compound ID
44458224
Target and Pathway
Target(s) Endothelin-converting enzyme 1 Target Info Inhibitor [551263]
PANTHER Pathway Endothelin signaling pathway
WikiPathways SIDS Susceptibility Pathways
Corticotropin-releasing hormone
Endothelin Pathways
References
Ref 551263Aminophosphonate endothelin converting enzyme inhibitors: potency-enhancing and selectivity-improving modifications of phosphoramidon, Bioorg. Med. Chem. Lett. 4(10):1257-1262 (1994).
Ref 551263Aminophosphonate endothelin converting enzyme inhibitors: potency-enhancing and selectivity-improving modifications of phosphoramidon, Bioorg. Med. Chem. Lett. 4(10):1257-1262 (1994).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.